RxDoctor Payments Data

Marcus Duda, MD

Orthopaedic Surgery · Greensboro, NCNPI 1124065172

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Kerecis Limited accounts for 86.4% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $136,576 and has fallen 54.2% since, to $62,588 in 2025. Among orthopaedic surgery clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$288,995in general payments, 2019–2025

Across 145 payments — averaging $1993.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kerecis Limited$250K
  • Solventum Corporation$29K
  • KCI USA, Inc.$10K
  • Zimmer Biomet$302
  • Tactile Systems Technology Inc$97
  • Johnson & Johnson$33
  • plus $84 from 3 others
$192,431in research payments, 2019–2025

Across 10 payments — averaging $19,243 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kerecis Limited$192K

What the payments were for

  • Consulting fees$150,38852%
  • Speaking & faculty fees$92,71132%
  • Travel & lodging$26,8689%
  • Food & beverage$5,2792%
  • Education$13,7505%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$288,995 in reported general payments places this provider in the 90th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$161,791
Medicare patients
215
Services billed
2,008

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Daptomycin18$4,094
Doxycycline Hyclate70$1,275
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen131$1,133
Colchicine13$1,047
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen77$670
Gabapentin30$437
Allopurinol42$323
Nitroglycerin PatchNitroglycerin14$282
Oxycodone Hcl34$239
Ciprofloxacin Hcl17$223
Pregabalin13$204
Mupirocin20$181
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim19$179
Prednisone57$150
Methocarbamol18$95

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →